|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0134 - 0.0176|
|52 Week Range||0.0100 - 0.1200|
|Beta (3Y Monthly)||-1.50|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Gala Pharmaceutical, Inc. (GLPH), a provider of cannabis testing in Southern California, today announced that it has completed construction of its cannabis testing facility in Long Beach, California. The company is currently in the process of ordering equipment and begin the initial steps towards ISO17025 accreditation. Gala Pharmaceutical is looking forward to capturing the lucrative southern California cannabis testing market.
IRVINE, Calif., March 14, 2019 -- IRVINE, Calif., March 13, 2019-- Gala Pharmaceutical, Inc. (GLPH), a provider of cannabis testing in Southern California, today announced that.
Gala Pharmaceutical, Inc. (GLPH), a provider of cannabis testing in Southern California, today announced that Gala Pharmaceutical Inc. will be presenting at the World CBD Expo (www.worldcbdexpo.com), one of the largest conferences focused on increasing the awareness of the benefits of CBD across various industries and consumer groups. The presentation is expected to discuss the benefits and the current market opportunities of CBD. In addition, the discussion will include Gala Pharmaceutical’s potential role in this emerging market as well as its intended rollout in 2019 of its state-of-the-art cannabis testing facility in Southern California.
Gala Pharmaceutical California Inc., a subsidiary of Gala Pharmaceutical, Inc. (GLPH), today announced it has received a Temporary License from the State of California for its flagship cannabis testing facility to be located in Long Beach, California. The Company expects to begin construction on the state-of-the-art facility as soon as it receives final building permits from the City. Gala Pharmaceutical's CEO Dr. Rehman looks forward to meeting the needs of a market that he describes as under-served. “It is common knowledge that a lack of ISO certified labs in California has caused a bottleneck in meeting the demand for quality, lab tested cannabis products.
Gala Pharmaceutical, Inc. (GLPH), a robust and burgeoning Analytical testing company, today announced notable progress toward opening its doors and serving its rapidly growing market. The Company’s application to operate a TYPE 8 Medical Cannabis Testing Lab has been deemed complete by the City of Long Beach and, through its subsidiary, Gala Pharmaceutical California, Inc., has filed for its California state license. In addition, Gala has submitted the application for its building permit.